A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

NCT05757869 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

20284

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Milvexian
DRUG: Apixaban
DRUG: Placebo
DRUG: Apixaban Placebo

Sponsor

Janssen Research & Development, LLC

Collaborators

[object Object]